z-logo
open-access-imgOpen Access
Epigenetic regulation of the Plasmodium falciparum genome
Author(s) -
Michael F. Duffy,
Shamista A. Selvarajah,
Gabrielle A. Josling,
Michaela Petter
Publication year - 2013
Publication title -
briefings in functional genomics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.22
H-Index - 67
eISSN - 2041-2647
pISSN - 2041-2649
DOI - 10.1093/bfgp/elt047
Subject(s) - biology , euchromatin , chromatin , epigenetics , plasmodium falciparum , genetics , chia pet , regulation of gene expression , heterochromatin , chromatin remodeling , histone , epigenome , gene silencing , gene , genome , gene expression , microbiology and biotechnology , malaria , dna methylation , immunology
Recent research has highlighted some unique aspects of chromatin biology in the malaria parasite Plasmodium falciparum. During its erythrocytic lifecycle P. falciparum maintains its genome primarily as unstructured euchromatin. Indeed there is no clear role for chromatin-mediated silencing of the majority of the developmentally expressed genes in P. falciparum. However discontinuous stretches of heterochromatin are critical for variegated expression of contingency genes that mediate key pathogenic processes in malaria. These range from invasion of erythrocytes and antigenic variation to solute transport and growth adaptation in response to environmental changes. Despite lack of structure within euchromatin the nucleus maintains functional compartments that regulate expression of many genes at the nuclear periphery, particularly genes with clonally variant expression. The typical components of the chromatin regulatory machinery are present in P. falciparum; however, some of these appear to have evolved novel species-specific functions, e.g. the dynamic regulation of histone variants at virulence gene promoters. The parasite also appears to have repeatedly acquired chromatin regulatory proteins through lateral transfer from endosymbionts and from the host. P. falciparum chromatin regulators have been successfully targeted with multiple drugs in laboratory studies; hopefully their functional divergence from human counterparts will allow the development of parasite-specific inhibitors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom